Clinical statement on the role of the surgeon and surgical issues relating to computed tomography screening programs for lung cancer.
about
Validation of the new IASLC/ATS/ERS lung adenocarcinoma classification: a surgeon's perspectiveScreening for lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines.The biomolecular era for thoracic surgeons: the example of the ESTS Biology Club.History and indications of uniportal pulmonary wedge resections.Non-small cell lung cancer: the new T1 categories.Age limits and frequency of negative scans: when should lung cancer screening end?Issues with implementing a high-quality lung cancer screening program.The importance of screening for lung cancer.Is surgery still the best management option for early stage NSCLC?Lung cancer screening: a systematic review of clinical practice guidelines.Implementation of lung cancer CT screening in the Nordic countries.Impact of Increasing Age on Cause-Specific Mortality and Morbidity in Patients With Stage I Non-Small-Cell Lung Cancer: A Competing Risks AnalysisBIONOTE e-nose technology may reduce false positives in lung cancer screening programmes†.Moving beyond disease-focused decision making: understanding competing risks to personalize lung cancer treatment for older adultsHow to deal with subcentimeter lung cancer: a moving target!Recommendations from the European Society of Thoracic Surgeons (ESTS) regarding computed tomography screening for lung cancer in Europe.Quality assurance and quantitative imaging biomarkers in low-dose CT lung cancer screening.Two livesShared decision-making conversations and smoking cessation interventions: critical components of low-dose CT lung cancer screening programsA benchmarking project on the quality of previous guidelines about the management of malignant pleural effusion from the European Society of Thoracic Surgeons (ESTS) Pleural Diseases Working Group
P2860
Q26858898-7DF46EDE-F697-4247-BB9B-AA14A1A70C39Q30543321-E5600D7D-4582-4A36-BD79-559CBBDF8A33Q33658238-27683F71-250E-42A6-8FBC-0B9560897F78Q37167111-DB6EF0A6-0D41-4E39-AD6F-16F973C7E5F6Q37664741-EE109B89-9776-4474-BF85-CA843572CD6FQ38134349-83F42E4E-2712-47DC-9EF9-5B405D34E08FQ38224354-247FB932-B1A2-48CB-94E6-B4BF179D95F6Q38243451-9A5639E6-0463-4281-890E-A1AE75BAFD7DQ38390136-FFB64CB6-1F19-48D7-8DAA-33B5C3E9BEADQ38625647-18BEF88A-F3B8-4048-9F59-E2E01D5A08A6Q39344447-166605D2-83E5-4EA0-81AA-3CEA897B0376Q40377554-97EB576F-08B7-4165-82BA-B4BA71DDC6FFQ40523088-89120FE7-6454-4A6D-84BA-99734D2017A9Q42322235-759280EC-5AFD-4CDB-BEBD-5EE40A44E126Q42369334-2D462ED1-4A20-434E-A948-38401020B336Q47986975-49A6BE5D-F7C4-46B0-B6C9-7E4C5B7DE489Q53793827-A0E7F6A8-355F-4157-B02D-98E0B9AEDDFBQ55012601-FC19527F-E67B-4357-9148-4388FD22FE5CQ57645241-EA0CE266-3155-4543-8C50-4CF1C9AF49AEQ58410405-81170012-0C81-41BF-BB3D-184195C67EC2
P2860
Clinical statement on the role of the surgeon and surgical issues relating to computed tomography screening programs for lung cancer.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Clinical statement on the role ...... ning programs for lung cancer.
@en
type
label
Clinical statement on the role ...... ning programs for lung cancer.
@en
prefLabel
Clinical statement on the role ...... ning programs for lung cancer.
@en
P2093
P50
P1476
Clinical statement on the role ...... ning programs for lung cancer.
@en
P2093
Carolyn M Dresler
Dominique Gossot
Douglas E Wood
Frank C Detterbeck
Hisao Asamura
John D Mitchell
Joseph R Newton
Mark S Allen
Matthew G Blum
Michael T Jaklitsch
P304
P356
10.1016/J.ATHORACSUR.2013.05.067
P407
P577
2013-07-01T00:00:00Z